EUVIMEDEUVIMED entdecken
Leitlinie

European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias

Asiiat Alieva, Elena Usova, Olga Reutova

European Atherosclerosis Journal · 2022

DOI: 10.56095/eaj.v1i2.14 ↗

Kurz gefasst

Leitlinie in der Zeitschrift European Atherosclerosis Journal, 2022. Verfasst von Asiiat Alieva und 2 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current clinical guidelines on lipid metabolism disorders are represented by the integration of relevant multicenter observational studies and registries aimed to identify best strategies in cardiovascular risk stratification, diagnostics and treatment of dyslipidemias. The approaches outlined in the European, Russian and American clinical guidelines look relevant to each other despite a range slightly different postulates, as they all demonstrate a general tendency to the importance of accurate risk stratification of patients and timely action on low-density lipoprotein cholesterol (LDL-C) levels when using effective lipid-lowering therapy.

Zitieren

APA

Alieva, A., Usova, E., & Reutova, O. (2022). European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias. European Atherosclerosis Journal. https://doi.org/10.56095/eaj.v1i2.14

Vancouver

Alieva A, Usova E, Reutova O. European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias. European Atherosclerosis Journal. 2022. doi:10.56095/eaj.v1i2.14

BibTeX
@article{Alieva2022,
  author = {Alieva, Asiiat and Usova, Elena and Reutova, Olga},
  title = {European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias},
  journal = {European Atherosclerosis Journal},
  year = {2022},
  doi = {10.56095/eaj.v1i2.14}
}
Kostenlos starten →